| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Silymarin | Amyloidosis | 1 | PM | 35563343 | 📋 | Local Insulin-Derived Amyloidosis Model Confronted with Silymarin: Histological Insights and Gene Expression of MMP, TNF-α, and IL-6 |
| Silymarin | Health and Disease | 3 | PM | 36014565 | 📋 | Mechanistic Insights into the Pharmacological Significance of Silymarin |
| Silymarin | Health and Disease | 4 | PM | 32455869 | 📋 | Silymarin and Derivatives: From Biosynthesis to Health Benefits |
| Silymarin | Health and Disease | 2 | PM | 32423098 | 📋 | Flavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications |
| Silymarin | Health and Disease | 1 | PM | 32134732 | 📋 | Silymarin: not just another antioxidant |
| Silymarin | Nausea | 1 | PM | 34030768 | 📋 | Pilot Study of Silymarin as Supplementation to Reduce Toxicities in Metastatic Colorectal Cancer Patients Treated with First-Line FOLFIRI Plus Bevacizumab |
